Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 02/7/14 → 11/18/16 |
Funding
- Puma Biotechnology Incorporated: $7,825.00
Study of Neratinib Plus Capecitabine vs.Lapatinib Plus Capecitabine in Patients with HER2 +Metastatic Breast Cancer Who Have Received Two or More Prior HER2-Directed Regimens in Metastatic Setting
- Cohen, Jules (PI)
- Lu, Janice (PI)
- Kudelka, Andrzej (CoPI)
Project: Research